Acquisition of Tiltan - Schedule of Allocation of the Purchase Price (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Mar. 31, 2026 |
Dec. 31, 2024 |
|
| Schedule of Allocation of the Purchase Price [Line Items] | |||
| Net tangible assets acquired | $ (86) | ||
| Deferred tax liabilities | (887) | ||
| Goodwill | 7,688 | $ 100,150 | |
| Assets acquired goodwill and liabilities assumed | 14,103 | ||
| Customer Relationships [Member] | |||
| Schedule of Allocation of the Purchase Price [Line Items] | |||
| Intangible assets | 4,663 | ||
| Developed technology [Member] | |||
| Schedule of Allocation of the Purchase Price [Line Items] | |||
| Intangible assets | $ 2,725 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of tangible and intangible assets other than cash transferred by acquirer as part of consideration transferred in business combination. Includes, but is not limited to, business or subsidiary, or both, of acquirer transferred to former owner of acquiree. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in excess of (less than) liability assumed plus goodwill in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|